Medical device maker Stereotaxis Inc. said Wednesday it sold 4.6 million shares of stock at $3.65 per share.
The company sold 4 million shares to the public, and the underwriters of the offering exercised an option to buy another 600,000 shares. Stereotaxis received $16.8 million in proceeds, not including discounts and expenses associated with the offering.
Stereotaxis said Oppenheimer & Co. is the book-running manager for the offering, and JMP Securities, Barrington Research Associates, and Madison Williams & Co. are the co-managers.
Shares of Stereotaxis rose 10 cents, or 2.9 percent, to $3.55 Wednesday. The stock was unchanged in aftermarket trading.